Theophylline Tablet, Extended Release
Product Images NDC 68462-356

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 68462-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 400 mg

Label for Theophylline (Anhydrous) Extended-Release Tablets 400 mg by Glenmark Pharmaceuticals Inc., USA. The label shows a package containing 100 tablets for oral use, marked Rx only. It includes storage instructions and manufacturing details from Glenmark Pharmaceuticals Limited in India.*

FDA Label Image

Label 600 mg

Theophylline (Anhydrous) Extended-Release Tablets 600 mg oral tablets label from Glenmark Pharmaceuticals Inc. The label states the product contains 100 tablets. It includes storage instructions and manufacturer details with an NDC barcode.*

FDA Label Image

Logo

FDA Label Image

Structure Theophylline

Chemical structure of the active ingredient theophylline, depicted as a nitrogen-containing heterocyclic compound with methyl and oxygen substituents on the ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.